Maternal fumonisin exposure and risk for neural tube defects: mechanisms in an in vivo mouse model

Birth Defects Res A Clin Mol Teratol. 2005 Jul;73(7):487-97. doi: 10.1002/bdra.20148.

Abstract

Background: Fumonisin B1 (FB1) is a mycotoxin produced by the fungus Fusarium verticillioides, a common contaminant of corn worldwide. FB1 disrupts sphingolipid biosynthesis by inhibiting the enzyme ceramide synthase, resulting in an elevation of free sphingoid bases and depletion of downstream glycosphingolipids. A relationship between maternal ingestion of FB1-contaminated corn during early pregnancy and increased risk for neural tube defects (NTDs) has recently been proposed in human populations around the world where corn is a dietary staple. The current studies provide an in vivo mouse model of FB1 teratogenicity.

Methods: Pregnant LM/Bc mice were injected with increasing doses of FB1 on GD 7.5 and 8.5, and exposed fetuses were examined for malformations. Sphingolipid profiles and (3)H-folate concentrations were measured in maternal and fetal tissues. Immunohistochemical expression of the GPI-anchored folate receptor (Folbp1) and its association with the lipid raft component, ganglioside GM1, were characterized. Rescue experiments were performed with maternal folate supplementation or administration of gangliosides.

Results: Maternal FB1 administration (20 mg/kg of body weight) during early gestation resulted in 79% NTDs in exposed fetuses. Sphingolipid profiles were significantly altered in maternal and embryonic tissues following exposure, and (3)H-folate levels and immunohistochemical expression of Folbp1 were reduced. Maternal folate supplementation partially rescued the NTD phenotype, whereas GM1 significantly restored folate concentrations and afforded almost complete protection against FB1-induced NTDs.

Conclusions: Maternal FB1 exposure altered sphingolipid metabolism and folate concentrations in LM/Bc mice, resulting in a dose-dependent increase in NTDs that could be prevented when adequate folate levels were maintained.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carrier Proteins / metabolism
  • Dose-Response Relationship, Drug
  • Female
  • Folate Receptors, GPI-Anchored
  • Folic Acid / metabolism
  • Folic Acid / therapeutic use
  • Fumonisins / toxicity*
  • G(M1) Ganglioside / antagonists & inhibitors
  • G(M1) Ganglioside / metabolism
  • G(M1) Ganglioside / pharmacology
  • Immunohistochemistry
  • Male
  • Maternal-Fetal Exchange
  • Mice
  • Mycotoxins / toxicity
  • Neural Tube Defects / chemically induced*
  • Neural Tube Defects / prevention & control
  • Placenta / metabolism
  • Pregnancy
  • Pregnancy, Animal*
  • Receptors, Cell Surface / metabolism
  • Sphingolipids / chemistry
  • Sphingolipids / metabolism
  • Sphingosine / analogs & derivatives
  • Sphingosine / chemistry
  • Sphingosine / metabolism
  • Teratogens / toxicity

Substances

  • Carrier Proteins
  • Folate Receptors, GPI-Anchored
  • Fumonisins
  • Mycotoxins
  • Receptors, Cell Surface
  • Sphingolipids
  • Teratogens
  • G(M1) Ganglioside
  • fumonisin B1
  • Folic Acid
  • Sphingosine
  • safingol